Guido Freckmann, MD
Institute for Diabetes Technology GmbH, Ulm, Germany

Dr. Guido Freckmann, MD, is Medical Director and General Manager of the “Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm” (IfDT), Ulm, Germany. The IfDT is an independent research organization specialized to diabetes technology.

Dr. Freckmann is diabetologist of the German Diabetes Association.

As a study physician at the IfDT, he was principle investigator for different studies, about e.g. CGM systems, development of closed loop systems or insulin pumps, and cooperates with several industrial and non-industrial partners. His expertise in blood glucose monitoring systems (BGMS) contributed to the IDT being accredited and internationally renowned as testing laboratory for BGMS following ISO 15197. Dr. Freckmann supports publication of study results and is author of several scientific papers about BGMS or CGMS accuracy and further topics.

In addition, he is chair of the IFCC Working Group on Continuous Glucose Monitoring (WG-CGM), member of the managing board of the diabetes technology working group (AGDT), the commission for laboratory diagnostics (KLD) and the Point-of-Care-Testing (POCT) working group of the German Diabetes Association.